John C.M. Farquhar Sells 22,562 Shares of Heartflow (NASDAQ:HTFL) Stock

Heartflow, Inc. (NASDAQ:HTFL) CEO John C.M. Farquhar sold 22,562 shares of the stock in a transaction that occurred on Wednesday, June 10th. The shares were sold at an average price of $28.50, for a total transaction of $643,017.00. Following the completion of the transaction, the chief executive officer owned 496,835 shares in the company, valued at $14,159,797.50. This represents a 4.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

John C.M. Farquhar also recently made the following trade(s):

• On Monday, May 11th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $29.12, for a total value of $657,005.44.
• On Friday, April 10th, John C.M. Farquhar sold 22,562 shares of Heartflow stock. The stock was sold at an average price of $26.72, for a total value of $602,856.64.
• On Wednesday, March 18th, John C.M. Farquhar sold 9,725 shares of Heartflow stock. The shares were sold at an average price of $25.00, for a total value of $243,125.00.

Heartflow Stock Up 8.4%

Shares of HTFL stock opened at $33.24 on Friday. Heartflow, Inc. has a fifty-two week low of $20.13 and a fifty-two week high of $41.22. The stock has a market cap of $2.87 billion and a P/E ratio of -10.69. The business has a fifty day simple moving average of $29.30 and a 200-day simple moving average of $28.34.

Heartflow (NASDAQ:HTFL) last posted its quarterly earnings results on Thursday, May 14th. The company reported ($0.16) EPS for the quarter, beating the consensus estimate of ($0.24) by $0.08. The business had revenue of $52.59 million during the quarter. Heartflow’s revenue was up 41.3% on a year-over-year basis. On average, sell-side analysts anticipate that Heartflow, Inc. will post -0.82 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Essential Partners LLC acquired a new stake in Heartflow in the 1st quarter valued at approximately $57,000. Bank of America Corp DE lifted its position in shares of Heartflow by 28.8% during the 1st quarter. Bank of America Corp DE now owns 111,702 shares of the company’s stock worth $2,718,000 after buying an additional 24,964 shares during the period. Janus Henderson Group PLC lifted its position in shares of Heartflow by 152.0% during the 1st quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company’s stock worth $53,063,000 after buying an additional 1,315,416 shares during the period. California State Teachers Retirement System increased its holdings in Heartflow by 41.9% during the 1st quarter. California State Teachers Retirement System now owns 29,371 shares of the company’s stock valued at $715,000 after purchasing an additional 8,678 shares in the last quarter. Finally, Royal Bank of Canada increased its holdings in Heartflow by 24.4% during the 1st quarter. Royal Bank of Canada now owns 137,421 shares of the company’s stock valued at $3,343,000 after purchasing an additional 26,912 shares in the last quarter.

Analyst Ratings Changes

HTFL has been the topic of several research reports. JPMorgan Chase & Co. dropped their price target on Heartflow from $40.00 to $35.00 and set an “overweight” rating on the stock in a research report on Thursday, March 19th. Canaccord Genuity Group decreased their price target on Heartflow from $43.00 to $37.00 and set a “buy” rating for the company in a research note on Friday, May 15th. Wells Fargo & Company increased their price target on Heartflow from $35.00 to $37.00 and gave the stock an “overweight” rating in a research note on Friday, May 15th. William Blair started coverage on Heartflow in a report on Monday, May 4th. They issued an “outperform” rating for the company. Finally, Piper Sandler restated an “overweight” rating on shares of Heartflow in a report on Thursday. Six analysts have rated the stock with a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $37.00.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.